Great Lakes Advisors’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.7M | Sell |
139,391
-12,927
| -8% | -$714K | 0.06% | 226 |
|
|
2025
Q1 | $7.37M | Buy |
152,318
+90,371
| +146% | +$4.37M | 0.07% | 223 |
|
|
2024
Q4 | $2.39M | Sell |
61,947
-7,678
| -11% | -$296K | 0.02% | 456 |
|
|
2024
Q3 | $3.13M | Sell |
69,625
-23,854
| -26% | -$1.07M | 0.03% | 421 |
|
|
2024
Q2 | $3.24M | Sell |
93,479
-3,681
| -4% | -$128K | 0.03% | 405 |
|
|
2024
Q1 | $2.81M | Buy |
97,160
+6,007
| +7% | +$174K | 0.02% | 428 |
|
|
2023
Q4 | $2.09M | Sell |
91,153
-50,406
| -36% | -$1.16M | 0.02% | 454 |
|
|
2023
Q3 | $2.36M | Sell |
141,559
-5,489
| -4% | -$91.6K | 0.02% | 439 |
|
|
2023
Q2 | $4.06M | Sell |
147,048
-3,436
| -2% | -$94.9K | 0.04% | 367 |
|
|
2023
Q1 | $3.46M | Buy |
+150,484
| New | +$3.46M | 0.03% | 427 |
|